Picture this: An FDA type is reclining in his Barcalounger, watching a few direct-to-consumer ads. Homework. Between bites of popcorn, the FDAer notices something strange. The rolling video in these ads shows healthy, smiling, carefree people--you can almost hear Snow White singing in the background. Almost. Because what you hear instead is a monotone voice reciting a litany of terrible side effects. Anxiety and sleeplessness, weight gain, blood clots that can be fatal, and so on.
What's a diligent agency to do, then? Mount a study [1]. The FDA intends to show a selection of drug ads to 1,000 people over the age of 40, and then ask questions about the subjects' impression of the drug. Are any verbal warnings penetrating the fairy-tale fog induced by those happy-go-lucky images? We'll see.
- read the Wall Street Journal's take [2] on this (sub. req.)
Related Articles:
Study: DTC ad spending on the rise. Report [3]
Does the FDA do enough to regulate drug ads? Report [4]
GAO: Improvements Needed in FDA's oversight of DTC ads. Report [5]
Links:
[1] http://www.fiercebiotech.com/story/ama-to-study-the-impact-of-drug-advertising/2005-06-22
[2] http://blogs.wsj.com/health/2007/08/21/the-pictures-are-happy-the-words-a-bummer/
[3] http://www.fiercepharma.com/story/study-dtc-ad-spending-rise/2007-08-16
[4] http://www.fiercebiotech.com/node/4957
[5] http://www.fiercebiotech.com/node/4951